Critical appraisal:PORT Meta-analysis Trialists Group 2005 3

From Cancer Guidelines Wiki

Critical Appraisal

Article being appraised

PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2005 Apr 18;(2):CD002142 Available from: http://www.ncbi.nlm.nih.gov/pubmed/15846628.


Applicable clinical question

Key Facts

Study Design

systematic review — randomised trials only

Number of Patients:

2343


Includes an economic evaluation

no

Evidence ratings

Level of evidence

I

Risk of bias
Low risk of bias Comments: Please replace this text and briefly describe the reasons for your rating


Size of effect
4 Reason for decision: When looking at overall effect of PORT on survival (all stages): HR 1.18(1.07-1.31, p=0.001)

On subset analysis, there was no clear evidence of a detriment for stage III patients. Hazard ratio for N2 disease 0.97 but with wide confidence intervals - therefore no clear evidence of detrimental or beneficial effect
NB. Largest trial contributing to systematic review shows worst effect of PORT due to deaths from intercurrent disease
Also detrimental effect of older RT techniques

Relevance of evidence
1 Additional comments: Please replace this text and briefly describe the reasons for your rating
Result of appraisal

Jutta's tick icon.png Included




Completed by

Lehman


Jutta's tick icon.png This appraisal has been completed.


Article
PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2005 Apr 18;(2):CD002142 Available from: http://www.ncbi.nlm.nih.gov/pubmed/15846628.
Assigned to
User:Margot.lehman
Topic area
Guidelines:Lung cancer/Treatment/Non-small-cell stage III operable
Clinical question
Form
Form:Critical appraisal


Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment